CME
Managing Immunotherapy-Related Adverse Events during Adjuvant Treatment for Resectable Melanoma
Host: Mario E. Lacouture, MD This educational initiative will enhance dermatologists' and surgeons' knowledge, clinical skills, and confidence in recognizing patients who may benefit from adjuvant systemic therapy and selecting individualized, a